These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7062188)

  • 1. Use of ticarcillin following carbenicillin-associated hepatotoxicity.
    Graft DF; Chesney PJ
    J Pediatr; 1982 Mar; 100(3):497-9. PubMed ID: 7062188
    [No Abstract]   [Full Text] [Related]  

  • 2. Ticarcillin compared with carbenicillin in the treatment of exacerbations of bronchopulmonary infection in cystic fibrosis.
    Penketh AR; Hodson ME; Batten JC
    Br J Dis Chest; 1983 Apr; 77(2):179-84. PubMed ID: 6871085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobramycin and ticarcillin therapy for exacerbations of pulmonary disease in patients with cystic fibrosis.
    Parry MF; Neu HC
    J Infect Dis; 1976 Aug; 134 Suppl():S194-7. PubMed ID: 823276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticarcillin.
    Med Lett Drugs Ther; 1977 Feb; 19(4):17-8. PubMed ID: 402545
    [No Abstract]   [Full Text] [Related]  

  • 5. Ticarcillin-induced cystitis. Cross-reactivity with related penicillins.
    Marx CM; Alpert SE
    Am J Dis Child; 1984 Jul; 138(7):670-2. PubMed ID: 6731385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of ticarcillin and of carbenicillin as prophylactic treatment in the oncologic surgery of head and neck (author's transl)].
    Dor P; Klastersky J
    Acta Chir Belg; 1976 Jan; 75(1):129-37. PubMed ID: 983629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergy to semisynthetic penicillins in cystic fibrosis.
    Moss RB; Babin S; Hsu YP; Blessing-Moore J; Lewiston NJ
    J Pediatr; 1984 Mar; 104(3):460-6. PubMed ID: 6323664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined clinical and laboratory studies with carbenicillin and ticarcillin: use in infections involving anaerobic bacteria.
    Westerman EL; Bradshaw MW; Ein ME; Smith NJ; Williams TW
    Am J Med Sci; 1978; 276(2):159-71. PubMed ID: 367159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cefoperazone sodium vs methicillin, ticarcillin, and tobramycin in treatment of pulmonary exacerbations in patients with cystic fibrosis.
    Jewett CV; Ledbetter J; Lyrene RK; Brasfield DM; Tiller RE
    J Pediatr; 1985 Apr; 106(4):669-72. PubMed ID: 3845095
    [No Abstract]   [Full Text] [Related]  

  • 10. Dose-dependent inhibition of experimental arterial thrombosis by carbenicillin and ticarcillin.
    Lyman BT; Johnson GJ; White JG
    Am J Pathol; 1978 Aug; 92(2):473-90. PubMed ID: 677271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pulmonary infections in patients with cystic fibrosis: a comparative study of ticarcillin and gentamicin.
    Parry MF; Neu HC; Merlino M; Gaerlan PF; Ores CN; Denning CR
    J Pediatr; 1977 Jan; 90(1):144-8. PubMed ID: 401521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative antibacterial effect of azlocillin, ticarcillin and carbenicillin on pseudomonas bacteria].
    Jotzoff M
    Med Welt; 1981 Sep; 32(39):1448-9. PubMed ID: 7300647
    [No Abstract]   [Full Text] [Related]  

  • 13. Anicteric carbenicillin hepatitis. Eight episodes in four patients.
    Wilson FM; Belamaric J; Lauter CB; Lerner AM
    JAMA; 1975 May; 232(8):818-21. PubMed ID: 1173185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of ticarcillin plus tobramycin versus carbenicillin plus gentamicin for the treatment of serious infections due to gram-negative bacilli.
    Parry MF; Neu HC
    Am J Med; 1978 Jun; 64(6):961-6. PubMed ID: 247895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticarcillin for treatment of serious infections with gram-negative bacteria.
    Parry MG; Neu HC
    J Infect Dis; 1976 Nov; 134(5):476-85. PubMed ID: 825582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Newer 'pyro'-active betalactam antibiotics].
    Bauernfeind A
    MMW Munch Med Wochenschr; 1979 Jan; 121(3):107-8. PubMed ID: 105262
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative efficacy and tolerance study of azlocillin and carbenicillin in patients with cystic fibrosis: a double blind study.
    Huang NN; Palmer J; Keith H; Schidlow D; Braverman S; Goldberg M
    J Antimicrob Chemother; 1983 May; 11 Suppl B():205-14. PubMed ID: 6352603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticarcillin: a review of its pharmacological properties and therapeutic efficacy.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1980 Nov; 20(5):325-52. PubMed ID: 7002527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins.
    Zobell JT; Waters CD; Young DC; Stockmann C; Ampofo K; Sherwin CM; Spigarelli MG
    Pediatr Pulmonol; 2013 Feb; 48(2):107-22. PubMed ID: 22949297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term ticarcillin desensitization by the continuous oral administration of penicillin.
    Brown LA; Goldberg ND; Shearer WT
    J Allergy Clin Immunol; 1982 Jan; 69(1 Pt 1):51-4. PubMed ID: 6798088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.